arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Protalix BioTherapeutics, Inc.

PLX

$2.45 ▲ +0.01 (+0.20%) at close

18 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Protalix BioTherapeutics, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $192.4M

Dividend Yield —

Revenue Growth -1.2% ↗

Op. Margin -10.4% ↘

ROIC -13.4% ↘

FCF / Share $-0.17 ↘

Trailing P/E —

Price / Book 4.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$52.74M

↓ -1.2% —

Net Income Profit after all expenses

$-6.60M

↓ -325.2% —

Operating Margin Operating profit as % of sales

-10.4%

↓ -242.2% 15th

FCF / Share Free cash flow per share

$-0.17

↓ -270.3% —

Long-Term Debt Long-term obligations

$912.00K

↓ -61.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	-1.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-115%)	-18.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-331%)	37.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+369%)	24.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+203%)	-39.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-588%)	15.0% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+88%)	59.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+647%)	77.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+874%)	109.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1265%)	110.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1285%)	-68.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-950%)	30.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+278%)	-69.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-974%)	315.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3848%)	26.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+228%)	1611.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+20048%)	—	—
EPS Growth YoY (%)	N/M	-66.7% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	N/M	50.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-181.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	-64.7% Weak ↑ Weak Improving Year-over-year change in net income	N/M	45.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-322.8% Weak ↓ Weak Declining Year-over-year change in net income	64.3% Excellent ↑ Excellent Improving Year-over-year change in net income	30.9% Excellent ↑ Excellent Improving Year-over-year change in net income	69.0% Excellent Excellent Year-over-year change in net income	-190.4% Weak Weak Year-over-year change in net income	N/M	N/M	-7.7% Weak ↑ Weak Improving Year-over-year change in net income	-139.2% Weak ↓ Weak Declining Year-over-year change in net income	68.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-26.0% Weak Weak Year-over-year change in net income	7.8% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	N/M	93.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-98.7% Weak Weak Year-over-year change in free cash flow	71.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	3.5% Caution ↑ Caution Improving Compound annual revenue growth over 3 years	11.7% Good ↑ Good Improving Compound annual revenue growth over 3 years	1.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-4.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	3.9% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	48.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	81.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	98.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	12.1% Good ↑ Good Improving Compound annual revenue growth over 3 years	-4.2% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-50.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	17.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	16.4% Excellent Excellent Compound annual revenue growth over 3 years	347.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-3.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-0.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	13.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	19.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	33.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	70.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	32.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	26.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-11.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	1.9% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	-8.1% Weak Weak Compound annual revenue growth over 5 years	103.8% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	-10.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-170%)	7.3% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-51%)	16.0% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+6%)	-27.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-282%)	-53.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-456%)	4.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-71%)	-19.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-231%)	-56.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-476%)	-188.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1360%)	-360.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2503%)	—	-184.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1331%)	-258.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1825%)	-34.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-333%)	-435.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3004%)	-451.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3108%)	—	—
Effective Tax Rate (%) (%)	-17.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	29.4% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-12.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-204%)	5.5% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-54%)	12.7% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+6%)	-31.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-361%)	-71.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-699%)	-10.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-186%)	-33.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-378%)	-77.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-744%)	-443.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3793%)	-319.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2760%)	—	-219.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1928%)	-265.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2310%)	-33.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-378%)	-435.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3730%)	-436.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3738%)	—	—
FCF Margin (%) (%)	-25.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	13.8% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-3.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-53.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-30.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-42.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-36.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-24.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-57.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-358.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-4.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-349.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	2.06x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.52x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.72x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	4.10x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.13x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	-0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.12x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.60x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	-1.22x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	6.4% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	30.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	126.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	267.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	12.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	28.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	91.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	263.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-172.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	36.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	87.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-465.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	147.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	209.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-159.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-6.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	5.3% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	12.4% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-23.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	4.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-50.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-32.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-70.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-46.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-13.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	6.8% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	24.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+65%)	140.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+835%)	—	24.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+61%)	26.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+73%)	50.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+234%)	272.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1717%)	294.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1866%)	—	53.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+259%)	103.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+588%)	—	140.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+834%)	256.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1607%)	-197.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1420%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	-0.02x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-103%)	-0.09x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-115%)	-1.62x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-369%)	-0.25x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-142%)	—	—	—
Interest Coverage (x)	—	2.56x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	3.81x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	-5.92x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	0.62x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.47x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.21x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.49x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-9.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.67x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.10x Weak Weak Operating income divided by interest expense Optimal: > 5x	-26.72x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	$-14.68M	$-19.76M	$-23.63M	$-17.11M	$-38.98M	$-18.27M	$-17.79M	$-37.81M	$-51.16M	$-63.28M	$-76.37M	$-53.85M	$-84.03M	$-46.61M	$-20.43M	$-35.90M	$-81.27M	$-42.60M
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	-0.04x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.10x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.45x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.18x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$0.67	$0.74	$0.97	$0.98	$0.87	$2.16	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.08	$0.04	$0.12	$-0.31	$-0.62	$-0.22	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.17	$0.10	$-0.04	$-0.53	$-0.27	$-0.92	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.60	$0.57	$0.46	$-0.20	$-0.13	$-0.78	$-4.74	$-3.56	$-2.18	$-0.80	$1.09	$-5.94	$-2.88	$-0.36	$-3.05	$-1.39	—	—
Tangible Book Value per Share (USD)	$0.60	$0.57	$0.46	$-0.20	$-0.13	$-0.78	$-4.74	$-3.56	$-2.18	$-0.80	$1.09	$-5.94	$-2.88	$-0.36	$-3.05	$-1.39	—	—
Basic Weighted Avg Shares (shares)	78.55M	72.53M	67.51M	48.47M	44.14M	29.15M	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$40.16M	$34.46M	$24.40M	$12.45M	$28.49M	$-30.75M	$-7.70M	$27.63M	$39.90M	$5.66M	$74.65M	$39.31M	$71.21M	$35.41M	$13.80M	$27.43M	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	$912.00K	$2.37M	$5.42M	$6.57M	—	—	—
Total Equity (USD)	$48.23M	$43.21M	$33.57M	$-10.64M	$-6.04M	$-27.04M	$-70.32M	$-52.88M	$-31.29M	$-9.96M	$10.87M	$-55.60M	$-26.95M	$-3.36M	$-26.08M	$-11.32M	$15.88M	$44.35M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$52.74M	$53.40M	$65.49M	$47.64M	$38.35M	$62.90M	$54.69M	$34.24M	$19.24M	$9.20M	$4.36M	$13.65M	$10.48M	$34.87M	$8.39M	$6.64M	$388.00K	—
Depreciation Expense (USD)	$1.47M	$1.30M	$1.19M	$1.09M	$1.12M	$1.30M	$1.62M	$1.67M	$1.92M	$1.98M	$2.37M	$3.14M	$3.54M	—	—	—	—	—
Net Income, GAAP (USD)	$-6.60M	$2.93M	$8.31M	$-14.93M	$-27.58M	$-6.52M	$-18.28M	$-26.46M	$-85.28M	$-29.36M	$58.04M	$-29.94M	$-27.79M	$-11.62M	$-36.53M	$-29.00M	$-31.44M	—
Operating Cash Flow (USD)	$-11.99M	$8.67M	$-1.32M	$-25.00M	$-10.29M	$-26.11M	$-19.36M	$-7.74M	$-9.99M	$-32.10M	$-24.28M	—	—	$635.00K	$-23.57M	$-38.46M	$44.45M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters

Protalix BioTherapeutics, Inc.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PLX with peers